Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

BACKGROUND: Recent in vitro and animal experiments suggest that peroxisome proliferation-activated receptor gamma (PPARɣ) agonist medications, such as antidiabetic glitazone (GTZ) drugs, are neuroprotective in models of Parkinson’s disease (PD). These findings have not been tested in humans. We hypo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS Med
Hlavní autoři: Brauer, Ruth, Bhaskaran, Krishnan, Chaturvedi, Nishi, Dexter, David T., Smeeth, Liam, Douglas, Ian
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511413/
https://ncbi.nlm.nih.gov/pubmed/26196151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001854
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky